Search Results - Knab, LI

  • Showing 1 - 11 results of 11
Refine Results
  1. 1
    Impact testing of concrete

    Impact testing of concrete by Clifton, J.R., Knab, L.I.

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Cumulative damage of reinforced concrete subjected to repeated impact

    Cumulative damage of reinforced concrete subjected to repeated impact by Knab, L.I., Clifton, J.R.

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    Fluorescent thin sections to observe the fracture zone in mortar

    Fluorescent thin sections to observe the fracture zone in mortar by Knab, L.I., Walker, H.N., Clifton, J.R., Fuller, E.R.

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  4. 4
    Effects of maximum void size and aggregate characteristics on the strength of mortar

    Effects of maximum void size and aggregate characteristics on the strength of mortar by Knab, L.I., Clifton, J.R., Ings, J.B.

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  5. 5
    Evaluation of Test Methods for Measuring the Bond Strength of Portland Cement Based Repair Materials to Concrete

    Evaluation of Test Methods for Measuring the Bond Strength of Portland Cement Based Repair Materials to Concrete by Knab, LI, Spring, CB

    Get full text
    Items that this one cites
    Items that cite this one
    Magazinearticle
    Save to List
    Saved in:
  6. 6
    Development of an Agent-Based Model to Investigate Response Durability in Hemophilia B Patients Treated with the AAV-Based Coagulation Factor IX (FIX) Gene Therapy Etranacogene Dezaparvovec

    Development of an Agent-Based Model to Investigate Response Durability in Hemophilia B Patients Treated with the AAV-Based Coagulation Factor IX (FIX) Gene Therapy Etranacogene Dez... by Li, Yuezhe, Nandy, Partha, Jordie, Eric, Peppel, Karsten, Knab, Timothy, Kirouac, Daniel, Wilkins, A. Katharina, Nuthalapati, Silpa

    Published in Blood
    Get full text
    Article
    Save to List
    Saved in:
  7. 7
    ABCL-367 Quantitative Systems Pharmacology Modeling of Loncastuximab Tesirine Combined With Mosunetuzumab and Glofitamab Helps Guide Dosing for Patients With DLBCL

    ABCL-367 Quantitative Systems Pharmacology Modeling of Loncastuximab Tesirine Combined With Mosunetuzumab and Glofitamab Helps Guide Dosing for Patients With DLBCL by Li, Yuezhe, Wilkins, A. Katharina, Knab, Timothy, Keir, Chris, Boni, Joseph P.

    Get full text
    Article
    Save to List
    Saved in:
  8. 8
    Quantitative Systems Pharmacology Modeling of Loncastuximab Tesirine Combined With Mosunetuzumab and Glofitamab Helps Guide Dosing for Patients With DLBCL

    Quantitative Systems Pharmacology Modeling of Loncastuximab Tesirine Combined With Mosunetuzumab and Glofitamab Helps Guide Dosing for Patients With DLBCL by Li, Yuezhe, Katharina Wilkins, A., Knab, Timothy, Keir, Chris, Boni, Joseph P.

    Get full text
    Article
    Save to List
    Saved in:
  9. 9
    ABCL-366 Quantitative Systems Pharmacology Model Predicts Combination Activity of CD19-Targeted Loncastuximab Tesirine Co-Dosed With a CD20/CD3 T-Cell Bispecific (Epcoritamab) in Diffuse Large B-Cell Lymphoma

    ABCL-366 Quantitative Systems Pharmacology Model Predicts Combination Activity of CD19-Targeted Loncastuximab Tesirine Co-Dosed With a CD20/CD3 T-Cell Bispecific (Epcoritamab) in D... by Li, Yuezhe, Wilkins, A. Katharina, Davis, Jimena, Knab, Timothy, Keir, Chris, Boni, Joseph P.

    Get full text
    Article
    Save to List
    Saved in:
  10. 10
    Quantitative Systems Pharmacology Model Predicts Combination Activity of CD19-Targeted Loncastuximab Tesirine Co-Dosed With a CD20/CD3 T-Cell Bispecific (Epcoritamab) in Diffuse Large B-Cell Lymphoma

    Quantitative Systems Pharmacology Model Predicts Combination Activity of CD19-Targeted Loncastuximab Tesirine Co-Dosed With a CD20/CD3 T-Cell Bispecific (Epcoritamab) in Diffuse La... by Li, Yuezhe, Katharina Wilkins, A., Davis, Jimena, Knab, Timothy, Keir, Chris, Boni, Joseph P.

    Get full text
    Article
    Save to List
    Saved in:
  11. 11
    Antimicrobial susceptibility of biliary stents do not predict infectious complications after whipple

    Antimicrobial susceptibility of biliary stents do not predict infectious complications after whipple by Knab, Lawrence M., Varsanik, Mary, Li, Ruojia, Chen, Caressa, Pak, Nancy, Eguia, Emanuel, Renz, Christian, Terrasse, Weston, Gauthier, Madeline, Ko, Caitlyn, Baker, Marshall, Parada, Jorge P., Abood, Gerard

    Published in Surgery
    Get full text
    Items that this one cites
    Article
    Save to List
    Saved in:

Search Tools: